Psoriasis Drugs Market Analysis – Global Industry Size, Share, Trends and Forecast, 2018 – 2026

Acumen Research and Consulting has announced the addition of the “Psoriasis Drugs Market” report to their offering.

The Psoriasis Drugs Market Report 2018 is an in depth study analyzing the current state of the Psoriasis Drugs Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Psoriasis Drugs Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Psoriasis Drugs Market also discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Market Players as below:

Johnson & Johnson, Novartis International AG, Pfizer Inc, Merck and Co. Inc, Celgene Corporation, Janssen Biotech Inc, Stiefel Laboratories Inc, Takeda Pharmaceutical Company Limited, Amgen Inc., and AbbVie among others.

The major market segments of Psoriasis Drugs Market are as below:

Market By Therapeutic Class

  • Tumor Necrosis Factor Inhibitor

Adalimumab

Etanercept

Infliximab

  • Interleukin Inhibitors

Ustekinumab

Secukinumab

Ixekizumab

Brodalumab

  • Vitamin-D Analogues

Calcitriol

Calcipotriol

Tacalcitol

Others

Market By Drugs

  • Topicals

Over-the-counter (OTC) topicals

Topical non-steroids

Topical steroids

  • Systemic

Retinoid

Cyclosporine

Methotrexate

  • Biologics

Tumor Necrosis Factor (TNF) Inhibitors

Interleukin 12 and 23 (IL-12/23) Inhibitors

Interleukin 17 (IL-17) Inhibitors

T-cell Inhibitors

Market By Geography

North America

  • U.S.
  • Canada
  • Mexico

Europe

  • UK
  • France
  • Germany
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Chile
  • Rest of LATAM

Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • Rest of MEA

Ask Query Here: frank@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

Table Of Contents:

Click Here To Get TOC’s: https://www.acumenresearchandconsulting.com/tentative-table-of-content/851

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/851

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *

   Contact: +14079154157 | +14089009135 | Email: info@storyoffuture.com

Scroll to Top